Skip to main content
Premium Trial:

Request an Annual Quote

Medcan Clinic Offering Pathway Genomics' Genetic Test

NEW YORK (GenomeWeb News) – Pathway Genomics announced today an agreement to offer its personalized genetic testing services through the Medcan Clinic, Canada's largest private healthcare clinic.

Medcan will provide in-person counseling by a certified genetic counselor in conjunction with Pathway's test called The Personal Genome Test. The test uses a saliva sample and reports on a patient's response to certain drugs and propensity to develop disease such as heart disease, type 2 diabetes, and cancer.

Financial and other terms of the deal were not disclosed.

"Medcan is a leader in providing personalized and preventive health care to the Canadian people," Pathway CEO Jim Plante said in a statement. "Pathway's extensive offering of genetic testing services enhances Medcan's genetics program, and allows the clinic to offer highly personalized and clinically actionable genetic information to its patients."

San Diego-based Pathway announced in October an agreement to offer its test through the Scripps Center for Executive Health.

The Scan

Suicidal Ideation-Linked Loci Identified Using Million Veteran Program Data

Researchers in PLOS Genetics identify risk variants within and across ancestry groups with a genome-wide association study involving veterans with or without a history of suicidal ideation.

Algorithm Teases Out Genetic Ancestry in Individuals at Biobank Scale

Researchers develop an algorithm known as Rye to tease apart ancestry fractions in admixed individuals at a biobank-scale, applying it to 488,221 UK Biobank participants in Nucleic Acids Research.

Multi-Ancestry Analysis Highlights Comparable Common Variants at Complex Trait-Linked Loci

Researchers in Nature Genetics examine common variants implicated in more than three dozen conditions, estimating genetic effect similarities across ancestry tracts in admixed individuals.

Sick Newborns Selected for WGS With Automated Pipeline

Researchers successfully prioritized infants with potential Mendelian conditions for whole-genome sequencing or rapid whole-genome sequencing, as they report in Genome Medicine.